Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, Perl AE, Travers KJ, Wang S, Hunt JP, Zarrinkar PP, Schadt EE, Kasarskis A, Kuriyan J, Shah NP
Nature. 2012 Apr 15;485(7397):260-3. doi: 10.1038/nature11016.
PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article